Skip to main content

Table 1 Baseline patient demographics

From: A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung disease

Characteristics IPF
(n = 330)
CTD-ILD
(n = 672)
Fibrotic HP
(n = 135)
Unclassifiable
(n = 343)
Age, years 68 ± 8 57 ± 13 62 ± 12 65 ± 12
Male 246 (75%) 209 (31%) 59 (44%) 185 (54%)
BMI, kg/m2 29 ± 5 28 ± 6 31 ± 6 30 ± 6
Current or past smoking 263 (80%) 335 (50%) 73 (54%) 217 (63%)
 Smoking pack-years 21 (2–37) 0 (0–18) 4 (0–21) 8 (0–28)
Baseline lung function     
 FVC, %-predicted 80 ± 18 77 ± 19 75 ± 19 81 ± 20
 DLCO, %-predicted 60 ± 18 63 ± 20 62 ± 19 65 ± 21
  1. Values represent mean ± standard deviation, number (percent), or median (interquartile range)
  2. BMI body mass index, FVC forced vital capacity, DLCO diffusing capacity of the lung for carbon monoxide, IPF idiopathic pulmonary fibrosis, CTD-ILD connective tissue disease-associated ILD, HP hypersensitivity pneumonitis